Illumina Receives Second Information Request from FTC in Bid for Complete Genomics; BGI Extends its Offer | GenomeWeb

NEW YORK (GenomeWeb News) – Illumina said in a regulatory filing after the close of the market on Thursday that it has received a second request from the US Federal Trade Commission for additional information related to the company’s effort to acquire Complete Genomics.

Separately, BGI-Shenzhen said also on Thursday that it has extended its cash tender offer for Complete Genomics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.